Evidence map›Paper›PMID 22732667›Full record

ArticlePeptides2012

Surface masking shapes the traffic of the neuropeptide Y Y2 receptor.

Michael S Parker, Renu Sah, Steven L Parker

Abstract read
In one paragraph

Article in Peptides, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Michael S ParkerDepartment of Microbiology and Molecular Cell Sciences, University of Memphis, Memphis, TN 38152, USA.
Renu Sah
Steven L Parker
University of Cincinnati Medical Center · USUniversity of Memphis · USUniversity of Tennessee at Knoxville · US

Funding

BRAIN MONOAMINES AND LUTEINIZING HORMONE SECRETIONR01HD013703 · NICHD · UNIVERSITY OF UTAH · PI CROWLEY, WILLIAM R · 1985 to 2003
$786k
NICHD NIH HHS R01 HD013703NICHD NIH HHS R01-HD13703
6 · The paper itself

Abstract

The neuropeptide Y (NPY) Y2 receptor shows a large masked surface population in adherent CHO cells or in forebrain cell aggregates, but not in dispersed cells or in particulates from these sources. This is related to adhesion via acidic motifs in the extracellular N-terminal domain. Masking of the Y2 receptor is lifted by non-permeabilizing mechanical dispersion of cells, which also increases internalization of Y2 agonists. Mechanical dispersion and detachment by EDTA expose the same number of surface sites. As we have already shown, phenylarsine oxide (PAO), a cysteine-bridging agent, and to a lesser extent also the cysteine alkylator N-ethylmaleimide, unmask the surface Y2 sites without cell detachment or permeabilization. We now demonstrate that unmasking by permeabilizing but non-detaching treatment with cholesterol-binding detergents digitonin and edelfosine compares with and overlaps that of PAO. The caveolar/raft cholesterol-targeting macrolide filipin III however produces only partial unmasking. Depletion of the surface sites by N-terminally clipped Y2 agonists indicates larger accessibility for a short highly helical peptide. These findings indicate presence of a dynamic masked pool including majority of the cell surface Y2 receptors in adherent CHO cells. This compartmentalization is obviously involved in the low internalization of Y2 receptors in these cells.

Indexed as

Amino Acid SequenceAnimalsArsenicalsBinding SitesCell AdhesionChelating AgentsCHO CellsCricetinaeDigitoninEdetic AcidFilipinGuanosine 5'-O-(3-Thiotriphosphate)Guinea PigsHEK293 CellsHumansMolecular Sequence DataArsenicalsChelating AgentsDigitoninEdetic AcidFilipinGuanosine 5'-O-(3-Thiotriphosphate)neuropeptide Y2 receptoroxophenylarsinePeptide YYPertussis ToxinReceptors, Neuropeptide YSurface-Active Agents

Identifiers

PMID22732667
PMCPMC3440242
OpenAlexW1970130496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.